MarketsPharma & Biotech
$BMY
Bristol Myers Squibb
Stories that name Bristol Myers Squibb, newest first.
News, not investment advice.
- Healthcare & InsuranceUS measles cases hit 4,852, more than double all of 2025
- Health Tech66.3%Apple and Samsung watches flag sleep apnea. Medicare still requires a sleep test
- Healthcare & InsuranceEbola deaths top 5,000 as US flight check starts Nov. 3
- Healthcare & InsuranceFDA would double the vitamin D floor in infant formula
- Healthcare & InsuranceCMS tightens rules on 54 organ groups as 100,000 wait
- Biotech & Genomics27%FDA approves Voceryq, first plasmid DNA immunotherapy
- Employer Benefits & ACA13%2027 ACA benchmark premiums rise 13% as signup opens Nov. 1
- Medicare17%17% on Medicare used drug discount sites. Those buys skip the Part D cap
- BreakthroughsUS colon cancer rate rose to 38.3 per 100,000 in 2023
- Women's HealthFDA drops boxed warning on 3 more menopause patches
- AI in Care46%46% of Americans want AI kept out of insurance claims
- Health Tech$365Function Health adds Withings scale and blood pressure data
Bristol Myers Squibb